NCT03747523View on ClinicalTrials.gov

Pilot Study: The Effect of Ergocalciferol on Plasma Mucin-1 Levels

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

March 12, 2019

Primary Completion Date

December 20, 2019

Study Completion Date

January 27, 2020

Conditions
Ergocalciferol
Interventions
DRUG

Ergocalciferol

Investigational drug will be administered to eligible participants in a single dose of 200,000 USP units vitamin D

Trial Locations (1)

27157

Wake Forest University Health Sciences, Winston-Salem

All Listed Sponsors
lead

Wake Forest University Health Sciences

OTHER

NCT03747523 - Pilot Study: The Effect of Ergocalciferol on Plasma Mucin-1 Levels | Biotech Hunter | Biotech Hunter